February 12: The Week in Cancer News
An FDA committee votes to recommend holding off on approval of an immunotherapy for early-stage triple-negative breast cancer, and more news of the week from Cancer Today.
Home > Patients, Caregivers, and Advocates > Research > February 12: The Week in Cancer News
An FDA committee votes to recommend holding off on approval of an immunotherapy for early-stage triple-negative breast cancer, and more news of the week from Cancer Today.